ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Interventional Cardiology

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,612Medicare Part D Prescriptions Filled, Including Refills

Rank: 2 out of 36

$1.06M Total Retail Price of All Prescriptions

Rank: 3 out of 36

1,223 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
21% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

1% of this provider’s 1,223 patients filled at least one prescription for a schedule three drug, compared to an average of 2%.

Risky Drugs to Seniors

0% of this provider’s 15,081 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

32% of this provider’s prescriptions were for brand-name drugs, compared to an average of 28%.

Prescription Price

$64 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

14 is the average number of prescriptions (including refills) per patient, compared to an average of 14.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
METOPROLOL SUCCINATE 910 866 1 5
CARVEDILOL 850 767 2 1
SIMVASTATIN 775 699 3 3
CLOPIDOGREL 746 676 4 2
PLAVIX 585 529 5 7
RAMIPRIL 570 522 6 21
NIFEDIPINE ER 554 540 7 29
FUROSEMIDE 457 375 8 6
TRIAMTERENE-HCTZ 451 413 9 56
ATORVASTATIN CALCIUM 442 365 10 10
CRESTOR 431 388 11 13
ISOSORBIDE MONONITRATE ER 398 343 12 14
PRAVASTATIN SODIUM 345 298 13 9
ATENOLOL 343 295 14 23
DIGOXIN 308 236 15 16
METOPROLOL TARTRATE 306 256 16 12
SOTALOL 295 254 17 39
AMLODIPINE BESYLATE 294 260 18 4
LISINOPRIL 290 242 19 8
POTASSIUM CHLORIDE 287 253 20 17
ZETIA 281 272 21 25
RANEXA 272 259 22 24
AMIODARONE HCL 271 256 23 22
LOSARTAN POTASSIUM 262 253 24 19
LOVAZA 253 251 25 46
PRADAXA 238 216 26 44
DILTIAZEM 24HR CD 232 209 27 53
FLECAINIDE ACETATE 217 209 28 76
BYSTOLIC 173 171 29 20
MULTAQ 167 167 30 52
LOSARTAN-HYDROCHLOROTHIAZIDE 165 161 31 47
TRILIPIX 147 125 32 70
SPIRONOLACTONE 133 104 33 26
DILTIAZEM 24HR ER 131 131 34 58
HYDROCHLOROTHIAZIDE 128 124 35 15
NISOLDIPINE 126 126 10 36 94
OMEPRAZOLE 118 107 37 31
EFFIENT 116 84 38 42
LISINOPRIL-HYDROCHLOROTHIAZIDE 115 102 39 50
PANTOPRAZOLE SODIUM 105 96 40 43
DIOVAN HCT 100 94 41 34
COREG CR 98 86 42 73
NIFEDICAL XL 96 88 43 67
TRICOR 96 96 43 61
LIPITOR 82 66 45 30
NIASPAN 81 80 46 59
FENOFIBRATE 81 81 46 49
GEMFIBROZIL 79 67 48 91
BENICAR HCT 75 75 49 71
CILOSTAZOL 71 70 50 33
ZOLPIDEM TARTRATE 70 65 51 54
KLOR-CON M20 67 67 52 66
BENICAR 65 55 53 51
VYTORIN 61 61 54 55
WARFARIN SODIUM 59 49 55 11
VERAPAMIL ER 57 50 56 69
CLONIDINE HCL 51 38 57 28
LEVOTHYROXINE SODIUM 50 50 58 41
AMLODIPINE BESYLATE-BENAZEPRIL 50 49 58 48
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 16, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.